Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Swahn

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Thrombosis Research|September 25, 2018
Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary interventionDimitrios Venetsanos, Tomas L Lindahl, Sofia Sederholm Lawesson, et al.
BMC Cardiovascular Disorders|May 5, 2016
Computed tomography coronary angiography in patients with acute myocardial infarction and normal invasive coronary angiographyGeorgios Panayi, Wouter G Wieringa, Joakim Alfredsson, et al.
Atherosclerosis|December 11, 2007
NK cell apoptosis in coronary artery disease: relation to oxidative stressWei Li, Caroline Lidebjer, Xi-Ming Yuan, et al.
European Heart Journal|February 10, 2009
Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trialsEva Swahn, Joakim Alfredsson, Rizwan Afzal, et al.
American Heart Journal|September 29, 2014
Impact of an invasive strategy on 5 years outcome in men and women with non-ST-segment elevation acute coronary syndromesJoakim Alfredsson, Tim Clayton, Peter Damman, et al.
European Heart Journal|December 25, 2004
Quantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II study populationMichael D Jacobsen, Galen S Wagner, Lene Holmvang, et al.
European Radiology|May 25, 2024
Liver fibrosis is associated with left ventricular remodeling: insight into the liver-heart axisCarl Edin, Mattias Ekstedt, Markus Karlsson, et al.
BMJ Open|June 1, 2022
Nationwide observational study of incidence, management and outcome of spontaneous coronary artery dissection: a report from the Swedish Coronary Angiography and Angioplasty registerHenrik Wilander, Christos Pagonis, Dimitrios Venetsanos, et al.
European Heart Journal|April 26, 2003
Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus studyLars Wallentin, Lott Bergstrand, Mikael Dellborg, et al.
BMJ Open|September 24, 2017
Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysisDimitrios Venetsanos, Sofia Sederholm Lawesson, Joakim Alfredsson, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Thrombosis Research|September 25, 2018
Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary interventionDimitrios Venetsanos, Tomas L Lindahl, Sofia Sederholm Lawesson, et al.
BMC Cardiovascular Disorders|May 5, 2016
Computed tomography coronary angiography in patients with acute myocardial infarction and normal invasive coronary angiographyGeorgios Panayi, Wouter G Wieringa, Joakim Alfredsson, et al.
Atherosclerosis|December 11, 2007
NK cell apoptosis in coronary artery disease: relation to oxidative stressWei Li, Caroline Lidebjer, Xi-Ming Yuan, et al.
European Heart Journal|February 10, 2009
Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trialsEva Swahn, Joakim Alfredsson, Rizwan Afzal, et al.
American Heart Journal|September 29, 2014
Impact of an invasive strategy on 5 years outcome in men and women with non-ST-segment elevation acute coronary syndromesJoakim Alfredsson, Tim Clayton, Peter Damman, et al.
European Heart Journal|December 25, 2004
Quantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II study populationMichael D Jacobsen, Galen S Wagner, Lene Holmvang, et al.
European Radiology|May 25, 2024
Liver fibrosis is associated with left ventricular remodeling: insight into the liver-heart axisCarl Edin, Mattias Ekstedt, Markus Karlsson, et al.
BMJ Open|June 1, 2022
Nationwide observational study of incidence, management and outcome of spontaneous coronary artery dissection: a report from the Swedish Coronary Angiography and Angioplasty registerHenrik Wilander, Christos Pagonis, Dimitrios Venetsanos, et al.
European Heart Journal|April 26, 2003
Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus studyLars Wallentin, Lott Bergstrand, Mikael Dellborg, et al.
BMJ Open|September 24, 2017
Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysisDimitrios Venetsanos, Sofia Sederholm Lawesson, Joakim Alfredsson, et al.
Pageof 12